Edition:
United Kingdom

ContraVir Pharmaceuticals Inc (CTRV.OQ)

CTRV.OQ on NASDAQ Stock Exchange Capital Market

0.35USD
18 Dec 2018
Change (% chg)

-- (--)
Prev Close
$0.35
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
48,383
52-wk High
$3.08
52-wk Low
$0.31

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.632
Jun '18 0.00 -0.378
Mar '18 0.00 -0.266
FY 2017 Dec '17 0.00 -0.139
Sep '17 0.00 -0.603
Sep '17 0.00 -0.075
Dec 0.00 -0.600
FY 2016 Jun '16 0.00 -1.300
Mar '16 0.00 -1.148
Dec 0.00 -0.910
Sep 0.00 -1.739
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 1 0.00 0.00 0.00 --
Year Ending Dec-18 1 0.00 0.00 0.00 --
Year Ending Dec-19 1 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Dec-18 1 -0.37 -0.37 -0.37 --
Year Ending Dec-18 1 -1.39 -1.39 -1.39 --
Year Ending Dec-19 1 -0.64 -0.64 -0.64 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.72 34.40
P/E High - Last 5 Yrs. -- 148.04 46.21
P/E Low - Last 5 Yrs. -- 47.80 24.59
Beta 1.54 1.08 0.91
Price to Sales (TTM) -- 49.54 6.22
Price to Book (MRQ) 5.85 10.17 5.20
Price to Tangible Book (MRQ) 12.10 13.82 6.74
Price to Cash Flow (TTM) -- 52.81 24.17
% Owned Institutions 9.99 3.75 1.77

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.44
Dividend Yield - 5 Year Avg -- 0.09 1.46
Dividend 5 Year Growth Rate -- 0.79 4.94
Payout Ratio(TTM) -- 7.05 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 129.94 8.17
Sales (TTM) vs TTM 1 Yr. Ago -- 47.86 6.50
Sales - 5 Yr. Growth Rate -- 22.77 10.44
EPS (MRQ) vs Qtr. 1 Yr. Ago 117.49 75.89 23.27
EPS (TTM) vs TTM 1 Yr. Ago 53.86 -- --
EPS - 5 Yr. Growth Rate -- 12.03 10.50
Capital Spending - 5 Yr. Growth Rate -- 9.25 14.59

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.28
Current Ratio (MRQ) 4.48 3.43 3.10
LT Debt to Equity (MRQ) 0.00 18.73 11.49
Total Debt to Equity (MRQ) 0.00 31.44 16.03
Interest Coverage (TTM) -- -43.28 30.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.30 54.44
Gross Margin - 5 Yr. Avg. -- 60.56 52.36
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.00 13.16
Operating Margin (TTM) -- -184.95 6.07
Operating Margin - 5 Yr. Avg. -- -126.44 8.47
Pre-Tax Margin (TTM) -- -175.72 7.02
Pre-Tax Margin - 5 Yr. Avg. -- -132.59 8.71
Net Profit Margin (TTM) -- -182.45 3.12
Net Profit Margin - 5 Yr. Avg. -- -136.99 4.90
Effective Tax Rate (TTM) -- 21.48 23.26
Effective Tax Rate - 5 Yr. Avg. -- 15.58 23.84

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 7,652,238 873,073,486
Net Income/Employee (TTM) -- 652,901 103,486,338
Receivable Turnover (TTM) -- 6.25 5.80
Inventory Turnover (TTM) -- 1.89 3.56
Asset Turnover (TTM) 0.00 0.32 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -94.57 6.46 11.45
Return on Assets - 5 Yr. Avg. -- 5.53 12.50
Return on Investment (TTM) -126.93 9.00 14.96
Return on Investment - 5 Yr. Avg. -- 6.86 16.23
Return on Equity (TTM) -- 10.14 16.53
Return on Equity - 5 Yr. Avg. -- 8.39 17.37
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 59.33 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for ContraVir Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 22.24 18.02 99 98
13 Week 10.71 5.32 99 94
26 Week -61.25 -64.20 12 98
52 Week -45.61 -53.90 40 68
YTD -48.33 -54.63 24 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 4.30%
# of Holders: 24
Total Shares Held: 713,190
3 Mo. Net Change: -15,983
# New Positions: 2
# Closed Positions: 4
# Increased Positions: 6
# Reduced Positions: 6
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.